ORCX vs. CDC

Last updated Jun 24, 2026

ORCX (Defiance Daily Target 2X Long ORCL ETF) and CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) are both exchange-traded funds - ORCX is a Leveraged Equities fund actively managed by Defiance, while CDC is a Large Cap Value Equities fund tracking the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. ORCX is actively managed, while CDC is passively managed. Over the past year, ORCX returned -60.79% vs 21.05% for CDC. At a 0.00 correlation, their price movements are largely independent. ORCX charges 1.29%/yr vs 0.37%/yr for CDC.

Performance

ORCX vs. CDC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Daily Target 2X Long ORCL ETF (ORCX) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ORCX achieves a -42.52% return, which is significantly lower than CDC's 13.97% return.

ORCX

• 1D: -11.52%
• 1M: -30.81%
• YTD: -42.52%
• 6M: -42.95%
• 1Y: -60.79%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CDC

• 1D: 1.02%
• 1M: 0.81%
• YTD: 13.97%
• 6M: 13.78%
• 1Y: 21.05%
• 3Y*: 12.98%
• 5Y*: 6.51%
• 10Y*: 10.51%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ORCX vs. CDC - Yearly Performance Comparison

	2026 (YTD)	2025
ORCX Defiance Daily Target 2X Long ORCL ETF	-42.52%	-16.64%
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	13.97%	6.09%

Correlation

The correlation between ORCX and CDC is -0.17, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.17
Correlation (All Time) Calculated using the full available price history since Feb 7, 2025	0.00

The correlation between ORCX and CDC shifts across timeframes, from -0.17 (1 year) to 0.00 (all time), reflecting how their relationship changes across market environments.

ORCX vs. CDC - Sectors Allocation Comparison

Sectors	ORCX	CDC
Technology	100.0%	5.0%
Basic Materials	-	0.0%
Communication Services	-	4.0%
Consumer Cyclical	-	7.0%
Consumer Defensive	-	15.1%
Energy	-	8.8%
Financial Services	-	24.0%
Healthcare	-	6.9%
Industrials	-	4.4%
Real Estate	-	0.0%
Utilities	-	23.9%

Return for Risk

ORCX vs. CDC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORCX

ORCX Risk / Return Rank: 5
ORCX Sharpe Ratio Rank: 5
ORCX Sortino Ratio Rank: 6
ORCX Omega Ratio Rank: 6
ORCX Calmar Ratio Rank: 3
ORCX Martin Ratio Rank: 4

CDC

CDC Risk / Return Rank: 72
CDC Sharpe Ratio Rank: 70
CDC Sortino Ratio Rank: 74
CDC Omega Ratio Rank: 64
CDC Calmar Ratio Rank: 77
CDC Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORCX vs. CDC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Daily Target 2X Long ORCL ETF (ORCX) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ORCX	CDC	Difference
Sharpe ratio: Return per unit of total volatility	-0.47	2.12	-2.59
Sortino ratio: Return per unit of downside risk	-0.23	3.09	-3.33
Omega ratio: Gain probability vs. loss probability	0.97	1.36	-0.39
Calmar ratio: Return relative to maximum drawdown	-0.71	3.73	-4.44
Martin ratio: Return relative to average drawdown	-1.01	13.12	-14.13

ORCX vs. CDC - Sharpe Ratio Comparison

The current ORCX Sharpe Ratio is -0.47, which is lower than the CDC Sharpe Ratio of 2.12. The chart below compares the historical Sharpe Ratios of ORCX and CDC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ORCX vs. CDC - Drawdown Comparison

The maximum ORCX drawdown since its inception was -85.98%, which is greater than CDC's maximum drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for ORCX and CDC.

Drawdown Indicators

	ORCX	CDC	Difference
Max Drawdown Largest peak-to-trough decline	-85.98%	-21.37%	-64.61%
Max Drawdown (1Y) Largest decline over 1 year	-85.98%	-5.67%	-80.31%
Max Drawdown (3Y) Largest decline over 3 years	—	-12.70%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-21.37%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-21.37%	—
Current Drawdown Current decline from peak	-82.28%	-0.49%	-81.79%
Average Drawdown Average peak-to-trough decline	-45.42%	-5.09%	-40.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	59.96%	1.61%	+58.35%

Volatility

ORCX vs. CDC - Volatility Comparison

Defiance Daily Target 2X Long ORCL ETF (ORCX) has a higher volatility of 49.57% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 3.44%. This indicates that ORCX's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORCX	CDC	Difference
Volatility (1M) Calculated over the trailing 1-month period	49.57%	3.44%	+46.13%
Volatility (6M) Calculated over the trailing 6-month period	84.44%	7.13%	+77.31%
Volatility (1Y) Calculated over the trailing 1-year period	129.20%	9.99%	+119.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	122.13%	12.52%	+109.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	122.13%	13.21%	+108.92%

ORCX vs. CDC - Expense Ratio Comparison

ORCX has a 1.29% expense ratio, which is higher than CDC's 0.37% expense ratio.

Dividends

ORCX vs. CDC - Dividend Comparison

ORCX has not paid dividends to shareholders, while CDC's dividend yield for the trailing twelve months is around 3.14%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	3.14%	3.36%	3.32%	4.24%	3.48%	2.65%	2.48%	3.04%	3.37%	2.81%	2.99%	3.17%
ORCX Defiance Daily Target 2X Long ORCL ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both ORCX and CDC in my portfolio?

ORCX and CDC have a correlation of -0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ORCX or CDC?

ORCX has higher volatility (49.57%) compared to CDC (3.44%). In terms of maximum drawdown, ORCX dropped -85.98% vs CDC's -21.37%.

Which ETF is better, ORCX or CDC?

On 1-year performance, CDC leads with 21.05% vs -60.79% for ORCX. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 3.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ORCX or CDC?

Over the 1-year period, CDC has performed better with a 21.05% return vs -60.79%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ORCX or CDC?

CDC is cheaper with a 0.37% expense ratio, compared with 1.29% for ORCX.

Which ETF pays a higher dividend yield, ORCX or CDC?

CDC has the higher dividend yield at 3.14%, compared with 0.00% for ORCX.

What is the main difference between ORCX and CDC?

ORCX is categorized as Leveraged Equities, while CDC is Large Cap Value Equities. They also come from different issuers: Defiance and Crestview. Their fees differ too: 1.29% for ORCX and 0.37% for CDC.

Which has better risk-adjusted returns?

CDC currently has the higher Sharpe Ratio (2.12 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.